Engineered T cells for cancer therapy are produced in the mouse bloodstream, avoiding the need to harvest T cells and manipulate them ex vivo.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Primary allogeneic mitochondrial mix (PAMM) transfer/transplant by MitoCeption to address damage in PBMCs caused by ultraviolet radiation
BMC Biotechnology Open Access 28 June 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Smith, T.T. et al. Nat. Nanotechnol. (2017) 10.1038/nnano.2017.57.
Khalil, D.N., Smith, E.L., Brentjens, R.J. & Wolchok, J.D. Nat. Rev. Clin. Oncol. 13, 394 (2016).
Kebriaei, P. et al. J. Clin. Invest. 126, 3363–3376 (2016).
Cox, D.B., Platt, R.J. & Zhang, F. Nat. Med. 21, 121–131 (2015).
Ivics, Z. Mol. Ther. 24, 851–854 (2016).
Klebanoff, C.A., Rosenberg, S.A. & Restifo, N.P. Nat. Med. 22, 26–36 (2016).
Blankenstein, T., Leisegang, M., Uckert, W. & Schreiber, H. Curr. Opin. Immunol. 33, 112–119 (2015).
Rosenberg, S.A. & Restifo, N.P. Science 348, 62–68 (2015).
Schumacher, T.N. & Schreiber, R.D. Science 348, 69–74 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Olweus, J. Manufacture of CAR-T cells in the body. Nat Biotechnol 35, 520–521 (2017). https://doi.org/10.1038/nbt.3898
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3898